Intestinal phosphate transport: a therapeutic target in chronic kidney disease and beyond?

Area of Science:

• Nephrology
• Gastroenterology
• Physiology

Background:

• Hyperphosphatemia is a significant complication in chronic kidney disease (CKD), linked to increased cardiovascular risks.
• Elevated serum phosphate, even within normal ranges, correlates with cardiovascular morbidity and mortality.
• Phosphate homeostasis relies on intestinal absorption and renal excretion, with intestinal mechanisms being less understood.

Purpose of the Study:

• To review current knowledge on intestinal phosphate transport and its role in phosphate homeostasis.
• To explore the intestine as a potential therapeutic target for managing phosphate imbalances.
• To highlight the significance of NaPi-IIb and potential alternative pathways in intestinal phosphate absorption.

Main Methods:

• Review of existing literature on intestinal phosphate transport mechanisms.
• Analysis of studies investigating NaPi-IIb function in phosphate homeostasis.
• Examination of data from knockout mouse models of CKD and phosphate transport.

Main Results:

• The intestinal sodium-phosphate cotransporter (NaPi-IIb) is a key player in phosphate absorption and homeostasis.
• NaPi-IIb may also be involved in sensing dietary phosphate and regulating hormonal factors.
• Studies indicate the existence of a sodium-independent pathway for intestinal phosphate absorption, as evidenced by NaPi-IIb knockout models.

Conclusions:

• The intestine is critical for maintaining phosphate balance and could be a target for treating hyperphosphatemia and hypophosphatemia.
• Further research into intestinal phosphate transport mechanisms is warranted.
• Understanding both NaPi-IIb-dependent and -independent pathways is essential for comprehensive phosphate management.